News | October 30, 2025
Lilly to invest $1.2 billion+ to boost oral medicine manufacturing capacity in US
Company plans to create 100 manufacturing jobs and up to 1,000 construction jobs
Company plans to create 100 manufacturing jobs and up to 1,000 construction jobs
The new CMC Process R&D Center represents a strategic investment in scale, sustainability, and specialization
Arora brings over 30 years of experience in the pharmaceutical and healthcare industry
Partnership combines MilliporeSigma’s chemistry and organoid expertise with Promega’s assay technologies
The event will be attended by 35,000+ industry professionals
The company's net income attributable to equity holders dropped to €2.80 billion from €2.82 billion last year
Glenmark’s Ropivacaine Hydrochloride Injection USP is bioequivalent and therapeutically equivalent to the reference listed drug Naropin Injection of Fresenius Kabi USA
Takeda will make an upfront payment of $1.2 billion, which includes a $100 million equity investment in Innovent
Global Phase 3 MANEUVER study highlights ongoing benefits and consistent safety profile
The expansion underscores Merck’s commitment to invest more than $70 billion in U.S. research, development and capital projects
Subscribe To Our Newsletter & Stay Updated
